2001
DOI: 10.1016/s0378-4274(00)00313-1
|View full text |Cite
|
Sign up to set email alerts
|

Induction of delayed-type hypersensitivity to sulfamethoxazole in mice: role of metabolites

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

2
9
0

Year Published

2003
2003
2023
2023

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 19 publications
(11 citation statements)
references
References 25 publications
2
9
0
Order By: Relevance
“…Chemical (thiol-depleting agents) and immunological (adjuvants) modulation, before SMX administration, confirmed that oxidative metabolism of SMX was required to stimulate a primary drug antigen-specific immune response in vivo. These observations are consistent with the demonstration of SMX metabolite-specific, but not SMX-specific, delayed-type hypersensitivity in mice (Choquet-Kastylevsky et al, 2001) and the original hapten hypothesis.…”
supporting
confidence: 91%
“…Chemical (thiol-depleting agents) and immunological (adjuvants) modulation, before SMX administration, confirmed that oxidative metabolism of SMX was required to stimulate a primary drug antigen-specific immune response in vivo. These observations are consistent with the demonstration of SMX metabolite-specific, but not SMX-specific, delayed-type hypersensitivity in mice (Choquet-Kastylevsky et al, 2001) and the original hapten hypothesis.…”
supporting
confidence: 91%
“…In rodent models, topical and systemic exposure to nitroso SMX primes naive CD4+ and CD8+ T cells. The T-cell response is dependent on protein processing, and liberated peptide antigens are presented to specific T-cell receptors in the context of MHC molecules (Choquet-Kastylevsky et al, 2001;Naisbitt et al, 2001Naisbitt et al, , 2002Farrell et al, 2003;Hopkins et al, 2005;Castrejon et al, 2010b). In contrast, administration of SMX does not activate immune cells.…”
Section: The Antigenicity and Immunogenicity Of Drugs That Acquirementioning
confidence: 99%
“…[18][19][20][21][22][23][24] SMX-NO is a potent immunogen in experimental models, and intracellular generation in dendritic cells is associated with costimulatory signaling. 10,19,20,[25][26][27][28] SMX-NO activates T lymphocytes from 90% of drug-naive volunteers after 14 to 35 days of in vitro culture. Furthermore, T cells from SMX-NO-immunized animals proliferate in the presence of SMX-NO-modified protein.…”
mentioning
confidence: 99%